Építés alatt – nem éles oldal
Belépés
LeállítvaFázis nélkül

Catheter Ablation of Ventricular Arrhythmia Reduces Skin Sympathetic Activity

Megadott ok: This study was closed before its planned primary completion date because early data indicated that VT ablation had little impact on sympathetic nerve activity in short-term follow up.

A legfontosabb adatok

Hol
Rochester (Egyesült Államok)A helyszín megnézése

Helyszínek itt: Egyesült Államok

  • Mayo Clinic in RochesterRochester, Egyesült ÁllamokNo longer taking part

A vizsgálat adatai

Ki végzi
Mayo Clinic
Azonosító
NCT04837183
A regiszteradat frissítve
2024. július 3.
Eredeti leírás
This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrhythmias respond to catheter ablation treatment.A teljes eredeti leírásKevesebb

This study is being done to determine whether there is an increase in sympathetic nerve activity before the onset of ventricular arrhythmias or irregular heartbeat rhythm. In addition, this study is looking at the relationship between sympathetic nerve activity and how patients with ventricular arrhythmias respond to catheter ablation treatment.

Bevonási feltételek: Patients who have non-sustained or sustained VA (VA ≥ 30s or receiving appropriate ICD therapies) are presented to the clinic or admitted to the hospital within 7 days of episodes; The causes of VA are associated with structural heart diseases including ischemic or nonischemic cardiomyopathy (idiopathic cardiomyopathy, hypertrophic cardiomyopathy, cardiac sarcoidosis or amyloidosis, and arrhythmogentic right ventricular dysplasia); Subjects are 18 years of age and older.

Kizáró feltételek: Allergic to skin patch electrodes; Female patients who is pregnant or of childbearing potential and not on a reliable form of birth control; Vulnerable populations (fetuses, neonates, pregnant women, prisoners, institutionalized individuals).

ClinicalTrials.gov NCT04837183